SASS: New Evidence on Safe PICC Securement for Pediatric Patients
When it comes to securing PICCs in pediatric patients, clinicians need a securement method they can trust, one that keeps lines stable, reduces complications, and protects the most vulnerable patients.
At the AVA 2025 Annual Scientific Meeting, a new poster by authors Cheryl Gillette, RN, VA-BC, and Kathy Greiser, BSN, RSN, VA-BC stood out for providing exactly what pediatric vascular access teams have been seeking: real-world, pediatric-specific evidence comparing Subcutaneous Anchored Securement Systems (SASS) to traditional Adhesive Securement Devices (ASDs) for 2.6 Fr PICCs.
This large retrospective review, spanning 946 pediatric cases across two leading children’s hospitals, uncovered a standout result: SASS dramatically reduces catheter migrations and dislodgements compared to ASD.
This translates to:
- Fewer restarts
- Fewer therapy interruptions
- Greater device stability
- A safer, smoother care experience
Just as important, the study found no increase in key complications such as infection, DVT, or CLABSI. This confirms that SASS delivers enhanced securement without compromising safety.
In a specialty where evidence can be limited and pediatric-specific solutions lag behind, this study provides the clarity teams have been waiting for. If you’re evaluating securement options or looking to strengthen your PICC program, this is a must-read. Access the Full Poster.
Eloquest Healthcare is committed to providing solutions that can help improve catheter securement and decrease complications while reducing unnecessary costs. For more information about SecurAcath®, please call 1‐877‐433‐7626 or complete this form.
